Granulocyte-macrophage colony-stimulating factor accelerates hematopoietic recovery after autologous bone marrow or peripheral blood progenitor cell transplantation and high-dose chemotherapy for lymphoma

Bone Marrow Transplantation

Volumn 18, Issue 2, 1996, Pages 293-299

  Colombat, Ph ^a   Delain, M ^a   Desbois, I ^a   Domenech, J ^a   Binet, Ch ^a   Tabah, I ^b   Lamagnere, J P ^a   Linassier, C ^a  

^a CHU BRETONNEAU   (France)

^b Schering Plough Sandoz Laboratories   (France)

Author keywords

ABMT; GM CSF; Lymphoma; PBPC; Recovery

Indexed keywords

ANTIBIOTIC AGENT; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADOLESCENT; ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; FEVER; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; LENGTH OF STAY; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STEM CELL TRANSPLANTATION; SUBCUTANEOUS DRUG ADMINISTRATION;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; CHILD; COMBINED MODALITY THERAPY; FEMALE; GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTORS, RECOMBINANT; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LENGTH OF STAY; LYMPHOMA; MALE; MIDDLE AGED; TRANSPLANTATION, AUTOLOGOUS;

EID: 0029789310     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Carella AM, Carlier P, Congiu A et al. Autologous bone marrow transplantation as adjuvant treatment for high-risk Hodgkin's disease in first complete remission after MOPP/ABVD protocol. Bone Marrow Transplant 1991; 8: 99-103.
2. Colombat Ph, Gorin NC, Lemonnier MP et al. The role of autologous bone marrow transplantation in 46 adults patients with non-Hodgkin's lymphomas. J Clin Oncol 1990; 8: 630-637.
3. Philip T, Chauvin F, Armitage J et al. Pharma International Protocol: pilot study of DHAP followed by involved field radiotherapy and BEAC with autologous bone marrow transplantation. Blood 1991; 77: 1587-1592.
4. Zinzani PL, Tura S, Mazza P et al. ABMT vs DHAP in residual disease following third generation regimens for aggressive non Hodgkin's lymphomas. Proc Fifth Int Conf on Malignant Lymphoma, 1993, Lugano, 41 (abstr. 41).
5. Van den Meer WM, Guiot HFL, van den Broeck PJ, van Furth R. Infections in bone marrow transplant recipients. Semin Hematol 1984; 21: 123-129.
6. Juttner CA, To LB, Ho IQK et al. Early lympho-hemopoietic recovery after autografting using peripheral blood stem cells in acute non-lymphoblastic leukemia. Transplant Proc 1988; 20: 40-43.
7. Kessinger A, Armitage JO, Smith DM et al. High-dose therapy and autologous peripheral stem cell transplantation for patients with lymphoma. Blood 1989; 4: 1260-1265.
8. Reiffers J, Castaigne S, Tilly H et al. Hematopoiesis reconstitution after autologous blood stem cell transplantation: a report of 46 cases. Plasma Ther Transf Technol 1987; 8: 360-362.
9. To LB, Roberts MM, Haylock DN et al. Comparison of hematological recovery times and supportive requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplant 1992; 9: 277-284.
10. Advani R, Chau NJ, Horning S et al. Granulocyte-macrophage colony-stimulating factor (GM-CSF) as an adjunct to autologous hemopoietic stem cell transplantation for lymphoma. Ann Intern Med 1992; 116: 183-189.
11. Nemunaitis J, Rabinowe SN, Singer JW et al. Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer. New Engl J Med 1991; 324: 1773-1178.
12. Pettengell R, Gurney H, Radford JA et al. Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial. Blood 1992; 80: 1430-1436.
13. Chao NJ, Schriber JR, Grimes K et al. Granulocyte colony-stimulating factor 'mobilized' peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy. Blood 1993; 81: 2031-2035.
14. Elias AD, Ayash L, Anderson KC et al. Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematopoietic support after high-dose intensification for breast cancer. Blood 1992; 79: 3036-3044.
15. Gianni AM, Tarella C, Siena S et al. Durable and complete hematopoietic reconstitution for autografting of GM-CSF-exposed peripheral blood progenitor cells. Bone Marrow Transplant 1990; 6: 143-145.
16. Haas R, Ho AD, Bredthauer U et al. Successful autologous transplantation of blood stem cells mobilized with recombinant human granulocyte-macrophage colony-stimulating factor. Exp Hematol 1990; 18: 94-98.
17. Gorin NC, Douay L, Laporte JP et al. Autologous bone marrow transplantation using marrow incubated with ASTA Z 7557 in adult acute leukemia. Blood 1986; 67: 1367-1376.
18. Pike BL, Robinson WA. Human bone colony growth in agargel. J Cell Physiol 1970; 76: 77-82.
19. Conover WJ. Practical Non-Parametric Statistics (2nd Edn). Wiley: New York, 1980.
20. Lehmann EL. Non-Parametric Statistical Methods Based on Ranks. Holden-day: Oakland, 1975.
21. Milpied N, Moreau P, Lamy T et al. Autologous bone marrow transplantation (ABMT) for adult disseminated histological aggressive non-Hodgkin's lymphoma in first partial remission. Prof Fifth Int Conf on Malignant Lymphoma, 1993, Lugano, 104 (abstr. 134).
22. Chopra R, McMillan AK, Linch DC et al. The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single center eight year study of 155 patients. Blood 1993; 81: 1137-1145.
23. Linch DC, Winfield D, Goldstone AH et al. Dose intensification with autologous bone marrow transplantation in relapsed and resistant Hodgkin's disease. Results of a BNLI randomized trial. Lancet 1993; 1: 1051-1056.
24. Haioun C, Lepage E, Gisselbrecht C et al. Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: a study of 464 patients. J Clin Oncol 1994; 12: 2543-2551.
25. Milpied N, Ifrah N, Kuentz M et al. Bone marrow transplantation for adult poor prognosis lymphoblastic lymphoma in first complete remission. Br J Haematol 1989; 73: 82-87.
26. Nademanee A, Schmidt GM, O'Donnel MR et al. High dose chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy during complete remission in adult patients with poor-risk aggressive lymphoma. A pilot study. Blood 1992; 80: 1130-1134.
27. Santini G, Coser P, Chisesi T. Autologous bone marrow transplantation for advanced stage adult lymphoblastic lymphoma in first complete remission. Ann Oncol 1991; 2: 181-185.
28. Gorin NC, Coiffier B, Hayat M et al. Recombinant human granulocyte-macrophage colony stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation with unpurged and purged marrow in non-Hodgkin's lymphoma: a double-blind, placebo-controlled trial. Blood 1992; 80: 1149-1157.
29. Khwasta A, Linch DC, Goldstone AH et al. Recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for malignant lymphoma: a British national lymphoma investigation double-blind, placebo-controlled trial. Br J Haematol 1992; 82: 317-323.
30. Link H, Boogaerts MA, Carella AM et al. A controlled trial of recombinant human granulocyte-macrophage colony-stimulating factor after total body irradiation, high-dose chemotherapy and autologous bone marrow transplantation for acute lymphoblastic leukemia or malignant lymphoma. Blood 1992; 80: 2188-2195.
31. Crawford J, Ozer H, Stoller R et al. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small cell lung cancer. New Engl J Med 1991; 325: 164-170.
32. Green JA, Trillet VN, Manegold C. R-metHuG-CSF (G-CSF) with CDE chemotherapy (CT) in small cell lung cancer (SCLC): interim results from a randomized placebo-controlled trial. Proc Am Soc Clin Oncol 1991; 10: (abstr. 243).
33. Hermann F, Schulz G, Lindemann A et al. Hematopoietic responses in patients with advanced malignancy treated with recombinant human granulocyte colony-stimulating factor. J Clin Oncol 1989; 7: 159-167.
34. Linch DC, Scarffe H, Proctor S et al. Randomized vehicle-controlled dose finding study of glycosylated recombinant human granulocyte colony-stimulating factor after bone marrow transplantation. Bone Marrow Transplant 1993; 11: 307-311.
35. Gulati SC, Bennett C. Role of granulocyte-macrophage colony-stimulating factor (GM-CSF) after autologous bone marrow transplantation for Hodgkin's disease. Ann Intern Med 1992; 116: 177-182.
36. Socinski MA, Elias A, Schnipper I et al. Granulocyte-macrophage colony-stimulating factor expands the circulating hemopoietic progenitor cell compartment in man. Lancet 1988; 1: 1194-1198.
37. Gianni AM, Siena S, Bregni M et al. Granulocyte-macrophage colony-stimulating factor to harvest circulating hematopoietic stem cells for transplantation. Lancet 1989; 2: 580-585.
38. + hematopoietic stem cells in the peripheral blood of high-dose cyclosphosphamide-treated patients: enhancement by intravenous recombinant human GM-CSF. Blood 1989; 74: 1905-1914.
39. Tarella C, Boccadoro M, Omede P et al. Role of chemotherapy and GM-CSF on hemopoietic progenitor cell mobilization in multiple myeloma. Bone Marrow Transplant 1993; 11: 271-277.
40. Haas R, Hohaus S, Egerer G et al. Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) subsequent to chemotherapy improves collection of blood stem cells for autografting in patients not eligible for bone marrow harvest. Bone Marrow Transplant 1992; 9: 459-465.
41. Huan SD, Hester J, Spitzer G et al. Influence of mobilized peripheral blood cells on the hematopoietic recovery by autologous marrow and human granulocyte-macrophage colony-stimulating factor after high-dose cyclophosphamide. etoposide and cisplatin. Blood 1992; 79: 3388-3393.
42. Peters WP, Kurtzberg J, Kirkpatrick G et al. rhGM-CSF-primed peripheral blood progenitor cells coupled with autologous bone marrow transplantation will eliminate absolute leukopenia following high-dose chemotherapy. Blood 1989; 74: (abstr. 50).
43. Boiron JM, Marit G, Faberes C et al. Collection of peripheral blood stem cells in multiple myeloma following high dose cyclophosphamide with and without recombinant human granulocyte-macrophage colony-stimulating factor. Bone Marrow Transplant 1993; 12: 49-55.
44. Villeval JL, Dührsen V, Morstyn G, Metcalf D. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on progenitor cells in patients with advanced malignancies. Br J Haematol 1990; 74: 36-41.
45. Schmitz N, Linch DC, Dreger P et al. Results of a randomized phase III study comparing filgrastim-mobilized peripheral blood progenitor cell transplantation with autologous bone marrow transplantation in patients with Hodgkin's disease and high grade non-Hodgkin's lymphoma. Bone Marrow Transplant 1995; 15 (Suppl. 2): (abstr. 643).